HRTX
Heron Therapeuti
0.3476$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.6% | -1.2% | -7.5% | -2.9% | -92.6% | -148.0% | -88.2% | -134.6% | -143.3% | -139.6% | 170.3% | -4,194.4% | -6,578.6% | -872.2% | -421.4% | -1,195.2% | – | – | – | – | -10,484.5% | -553.5% | -247.6% | -85.3% | -208.5% | -235.5% | -136.4% | -46.3% | -15.6% | -17.8% | |
| 7.5% | 7.0% | 7.0% | 2.5% | -3.5% | 9.3% | 8.3% | 9.5% | 5.8% | 8.3% | -4.5% | 70.1% | 111.7% | 28.2% | 17.4% | 27.7% | – | – | – | – | 85.9% | 5.0% | 2.0% | 1.4% | 3.2% | 3.5% | 2.7% | 2.3% | 1.7% | 1.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | 301.4% | 90.2% | 134.4% | 292.6% | – | – | – | – | 2,029.4% | 99.3% | 43.1% | 35.2% | 56.7% | 54.3% | 39.9% | 25.9% | 9.0% | 6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -58.7% | – | – | – | – | 2,030.1% | 99.4% | 43.2% | 35.3% | 57.6% | 56.1% | 39.5% | – | – | – | |
| 1.6% | -5.2% | -25.0% | -13.2% | -18.6% | -27.4% | -13.8% | -7.8% | 15.1% | -1.1% | 64.8% | 507.8% | -807.0% | -194.2% | -20.5% | 238.7% | – | – | – | – | 861.5% | -17.6% | -58.6% | 20.0% | -14.7% | -40.6% | -9.8% | 13.2% | -19.1% | -20.6% | |
| 3.7% | 16.3% | 13.5% | 1.5% | 5.3% | 6.3% | 7.4% | 5.2% | 3.6% | 5.9% | 3.5% | 116.7% | 80.8% | 0.2% | 6.0% | 79.4% | – | – | – | – | 245.1% | 8.3% | 11.8% | 4.9% | 7.7% | 3.5% | 1.7% | 1.2% | 1.2% | 0.2% | |
| -3.7% | -5.8% | -14.0% | -2.0% | 266.5% | 80.9% | 81.2% | 67.2% | -23.2% | 94.4% | -143.1% | 2,718.9% | 183.7% | 48.5% | -6.0% | -79.4% | – | – | – | – | 1,163.1% | 25.2% | -359.5% | -14.9% | 235.7% | 37.9% | -3.1% | 14.2% | 13.0% | 10.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.3% | – | – | – | – | 582.9% | 1,036.0% | 493.9% | 127.7% | 10.2% | 8.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3,909.3% | -81.3% | -32.3% | 0.0% | 0.0% | 172.5% | 0.0% | 19.2% | 0.0% | -8.2% | |
| 38.0% | 25.0% | -1.5% | 2.9% | -91.1% | 1.5% | 1.3% | 1.7% | 222.3% | 2.2% | 1.5% | 9,042.7% | 14.6% | 635.4% | 5.9% | 3,730.5% | – | – | – | – | 4,492.2% | 954.7% | 461.6% | 127.7% | 10.3% | 180.7% | 69.7% | 42.6% | 0.7% | 9.3% | |
| 1.6% | 18.0% | -23.0% | -2.0% | 82.8% | -65.5% | -5.8% | -65.7% | 55.8% | 14.7% | 28.6% | 7,567.2% | -6,380.2% | -188.3% | -421.5% | 2,455.9% | – | – | – | – | -4,829.2% | 426.3% | -145.5% | 27.4% | 37.5% | -16.9% | -69.8% | 10.5% | -2.0% | 1.8% | |
| -36.4% | -17.4% | -21.0% | -4.4% | -97.9% | -154.3% | -95.6% | -139.8% | -146.9% | -145.5% | 166.8% | -4,311.2% | -6,659.3% | -872.4% | -427.4% | -1,274.6% | – | – | – | – | -10,729.6% | -561.8% | -259.4% | -90.2% | -216.2% | -239.0% | -138.1% | -47.5% | -16.8% | -18.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.